Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death

Kumar Narayanan, Kyndaron Reinier, Audrey Uy-Evanado, Carmen Teodorescu, Lin Zhang, Harpriya Chugh, Gregory A. Nichols, Karen Gunson, Jonathan Jui, Sumeet S. Chugh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives The purpose of this study was to determine whether chronic obstructive pulmonary disease (COPD) is associated with sudden cardiac death (SCD) in the community. Background COPD is linked to cardiovascular mortality; an association with SCD has not been systematically investigated in the general population. Methods In the Oregon Sudden Unexpected Death Study (approximately 1 million population), adult SCD case subjects were compared with geographic control subjects with coronary artery disease. Detailed clinical and electrocardiographic risk marker information was obtained from medical records. The association of COPD with SCD in the overall population and in a propensity score-matched dataset was assessed with logistic models. Results SCD case subjects (n = 728; age 69.9 ± 13.7 years) were more likely than control subjects (n = 548; age 67.2 ± 11.3 years) to have left ventricular ejection fraction ≤&35% (27.5% vs. 12.0%; p <0.0001), COPD (30.8% vs. 12.8%, p <0.0001), diabetes mellitus (47.7% vs. 31.8%; p <0.0001), use short-acting beta-2 agonist agents (SBAs) (22.3% vs. 12.6%; p <0.0001), and less likely to use beta-blockers (60.6% vs. 66.4%; p = 0.03). In multivariable analysis, COPD was significantly associated with SCD (odds ratio [OR]: 2.2; 95% confidence interval [CI]: 1.4 to 3.5; p <0.001). There was no significant interaction between COPD and medications, but an interaction was identified between SBAs and beta-blockers (p = 0.04); SBAs were strongly associated with SCD in subjects not taking beta-blockers (OR: 3.3; 95% CI: 1.4 to 7.7; p = 0.005) but not in those taking beta-blockers (OR: 1.3; 95% CI: 0.7 to 2.3; p = 0.39). The COPD-SCD association was maintained in a propensity score-matched analysis. Conclusions COPD is associated with SCD risk in the community independent of medications, electrocardiographic risk markers, and left ventricular ejection fraction. Among other mechanisms, pro-arrhythmogenic right ventricular remodeling and systemic inflammation warrant further investigation.

Original languageEnglish (US)
Pages (from-to)381-387
Number of pages7
JournalJACC: Clinical Electrophysiology
Volume1
Issue number5
DOIs
StatePublished - Oct 1 2015

Fingerprint

Sudden Cardiac Death
Chronic Obstructive Pulmonary Disease
Propensity Score
Odds Ratio
Confidence Intervals
Stroke Volume
Population
Ventricular Remodeling
Sudden Death
Medical Records
Coronary Artery Disease
Diabetes Mellitus
Logistic Models
Inflammation
Mortality

Keywords

  • beta-2 agonist
  • COPD
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Narayanan, K., Reinier, K., Uy-Evanado, A., Teodorescu, C., Zhang, L., Chugh, H., ... Chugh, S. S. (2015). Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death. JACC: Clinical Electrophysiology, 1(5), 381-387. https://doi.org/10.1016/j.jacep.2015.06.005

Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death. / Narayanan, Kumar; Reinier, Kyndaron; Uy-Evanado, Audrey; Teodorescu, Carmen; Zhang, Lin; Chugh, Harpriya; Nichols, Gregory A.; Gunson, Karen; Jui, Jonathan; Chugh, Sumeet S.

In: JACC: Clinical Electrophysiology, Vol. 1, No. 5, 01.10.2015, p. 381-387.

Research output: Contribution to journalArticle

Narayanan, K, Reinier, K, Uy-Evanado, A, Teodorescu, C, Zhang, L, Chugh, H, Nichols, GA, Gunson, K, Jui, J & Chugh, SS 2015, 'Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death', JACC: Clinical Electrophysiology, vol. 1, no. 5, pp. 381-387. https://doi.org/10.1016/j.jacep.2015.06.005
Narayanan K, Reinier K, Uy-Evanado A, Teodorescu C, Zhang L, Chugh H et al. Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death. JACC: Clinical Electrophysiology. 2015 Oct 1;1(5):381-387. https://doi.org/10.1016/j.jacep.2015.06.005
Narayanan, Kumar ; Reinier, Kyndaron ; Uy-Evanado, Audrey ; Teodorescu, Carmen ; Zhang, Lin ; Chugh, Harpriya ; Nichols, Gregory A. ; Gunson, Karen ; Jui, Jonathan ; Chugh, Sumeet S. / Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death. In: JACC: Clinical Electrophysiology. 2015 ; Vol. 1, No. 5. pp. 381-387.
@article{b61992ca45cb44bd9f69484112d96caa,
title = "Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death",
abstract = "Objectives The purpose of this study was to determine whether chronic obstructive pulmonary disease (COPD) is associated with sudden cardiac death (SCD) in the community. Background COPD is linked to cardiovascular mortality; an association with SCD has not been systematically investigated in the general population. Methods In the Oregon Sudden Unexpected Death Study (approximately 1 million population), adult SCD case subjects were compared with geographic control subjects with coronary artery disease. Detailed clinical and electrocardiographic risk marker information was obtained from medical records. The association of COPD with SCD in the overall population and in a propensity score-matched dataset was assessed with logistic models. Results SCD case subjects (n = 728; age 69.9 ± 13.7 years) were more likely than control subjects (n = 548; age 67.2 ± 11.3 years) to have left ventricular ejection fraction ≤&35{\%} (27.5{\%} vs. 12.0{\%}; p <0.0001), COPD (30.8{\%} vs. 12.8{\%}, p <0.0001), diabetes mellitus (47.7{\%} vs. 31.8{\%}; p <0.0001), use short-acting beta-2 agonist agents (SBAs) (22.3{\%} vs. 12.6{\%}; p <0.0001), and less likely to use beta-blockers (60.6{\%} vs. 66.4{\%}; p = 0.03). In multivariable analysis, COPD was significantly associated with SCD (odds ratio [OR]: 2.2; 95{\%} confidence interval [CI]: 1.4 to 3.5; p <0.001). There was no significant interaction between COPD and medications, but an interaction was identified between SBAs and beta-blockers (p = 0.04); SBAs were strongly associated with SCD in subjects not taking beta-blockers (OR: 3.3; 95{\%} CI: 1.4 to 7.7; p = 0.005) but not in those taking beta-blockers (OR: 1.3; 95{\%} CI: 0.7 to 2.3; p = 0.39). The COPD-SCD association was maintained in a propensity score-matched analysis. Conclusions COPD is associated with SCD risk in the community independent of medications, electrocardiographic risk markers, and left ventricular ejection fraction. Among other mechanisms, pro-arrhythmogenic right ventricular remodeling and systemic inflammation warrant further investigation.",
keywords = "beta-2 agonist, COPD, sudden death",
author = "Kumar Narayanan and Kyndaron Reinier and Audrey Uy-Evanado and Carmen Teodorescu and Lin Zhang and Harpriya Chugh and Nichols, {Gregory A.} and Karen Gunson and Jonathan Jui and Chugh, {Sumeet S.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.jacep.2015.06.005",
language = "English (US)",
volume = "1",
pages = "381--387",
journal = "JACC: Clinical Electrophysiology",
issn = "2405-5018",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Chronic Obstructive Pulmonary Disease and Risk of Sudden Cardiac Death

AU - Narayanan, Kumar

AU - Reinier, Kyndaron

AU - Uy-Evanado, Audrey

AU - Teodorescu, Carmen

AU - Zhang, Lin

AU - Chugh, Harpriya

AU - Nichols, Gregory A.

AU - Gunson, Karen

AU - Jui, Jonathan

AU - Chugh, Sumeet S.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objectives The purpose of this study was to determine whether chronic obstructive pulmonary disease (COPD) is associated with sudden cardiac death (SCD) in the community. Background COPD is linked to cardiovascular mortality; an association with SCD has not been systematically investigated in the general population. Methods In the Oregon Sudden Unexpected Death Study (approximately 1 million population), adult SCD case subjects were compared with geographic control subjects with coronary artery disease. Detailed clinical and electrocardiographic risk marker information was obtained from medical records. The association of COPD with SCD in the overall population and in a propensity score-matched dataset was assessed with logistic models. Results SCD case subjects (n = 728; age 69.9 ± 13.7 years) were more likely than control subjects (n = 548; age 67.2 ± 11.3 years) to have left ventricular ejection fraction ≤&35% (27.5% vs. 12.0%; p <0.0001), COPD (30.8% vs. 12.8%, p <0.0001), diabetes mellitus (47.7% vs. 31.8%; p <0.0001), use short-acting beta-2 agonist agents (SBAs) (22.3% vs. 12.6%; p <0.0001), and less likely to use beta-blockers (60.6% vs. 66.4%; p = 0.03). In multivariable analysis, COPD was significantly associated with SCD (odds ratio [OR]: 2.2; 95% confidence interval [CI]: 1.4 to 3.5; p <0.001). There was no significant interaction between COPD and medications, but an interaction was identified between SBAs and beta-blockers (p = 0.04); SBAs were strongly associated with SCD in subjects not taking beta-blockers (OR: 3.3; 95% CI: 1.4 to 7.7; p = 0.005) but not in those taking beta-blockers (OR: 1.3; 95% CI: 0.7 to 2.3; p = 0.39). The COPD-SCD association was maintained in a propensity score-matched analysis. Conclusions COPD is associated with SCD risk in the community independent of medications, electrocardiographic risk markers, and left ventricular ejection fraction. Among other mechanisms, pro-arrhythmogenic right ventricular remodeling and systemic inflammation warrant further investigation.

AB - Objectives The purpose of this study was to determine whether chronic obstructive pulmonary disease (COPD) is associated with sudden cardiac death (SCD) in the community. Background COPD is linked to cardiovascular mortality; an association with SCD has not been systematically investigated in the general population. Methods In the Oregon Sudden Unexpected Death Study (approximately 1 million population), adult SCD case subjects were compared with geographic control subjects with coronary artery disease. Detailed clinical and electrocardiographic risk marker information was obtained from medical records. The association of COPD with SCD in the overall population and in a propensity score-matched dataset was assessed with logistic models. Results SCD case subjects (n = 728; age 69.9 ± 13.7 years) were more likely than control subjects (n = 548; age 67.2 ± 11.3 years) to have left ventricular ejection fraction ≤&35% (27.5% vs. 12.0%; p <0.0001), COPD (30.8% vs. 12.8%, p <0.0001), diabetes mellitus (47.7% vs. 31.8%; p <0.0001), use short-acting beta-2 agonist agents (SBAs) (22.3% vs. 12.6%; p <0.0001), and less likely to use beta-blockers (60.6% vs. 66.4%; p = 0.03). In multivariable analysis, COPD was significantly associated with SCD (odds ratio [OR]: 2.2; 95% confidence interval [CI]: 1.4 to 3.5; p <0.001). There was no significant interaction between COPD and medications, but an interaction was identified between SBAs and beta-blockers (p = 0.04); SBAs were strongly associated with SCD in subjects not taking beta-blockers (OR: 3.3; 95% CI: 1.4 to 7.7; p = 0.005) but not in those taking beta-blockers (OR: 1.3; 95% CI: 0.7 to 2.3; p = 0.39). The COPD-SCD association was maintained in a propensity score-matched analysis. Conclusions COPD is associated with SCD risk in the community independent of medications, electrocardiographic risk markers, and left ventricular ejection fraction. Among other mechanisms, pro-arrhythmogenic right ventricular remodeling and systemic inflammation warrant further investigation.

KW - beta-2 agonist

KW - COPD

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=84945244684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945244684&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2015.06.005

DO - 10.1016/j.jacep.2015.06.005

M3 - Article

AN - SCOPUS:84945244684

VL - 1

SP - 381

EP - 387

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

SN - 2405-5018

IS - 5

ER -